Literature DB >> 1155490

Tobramycin in renal impairment.

L D Bechtol, H R Black.   

Abstract

Calculated elimination rate constants of tobramycin were correlated with endogenous creatinine clearances in 128 normal subjects or patients with various degrees of renal impairment. A similar correlation was made with serum creatinine concentration in 85 subjects. Superimposition of these regression lines permitted calculation of daily maintenance dosage ranges for tobramycin in patients with all degrees of impairment of renal function as determined by either creatinine clearances or serum creatinine concentrations. These maintenance dosage ranges are presented in a simplified figure.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1155490     DOI: 10.1097/00000441-197505000-00004

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  8 in total

Review 1.  Clinical pharmacokinetics of aminoglycoside antibiotics.

Authors:  J C Pechere; R Dugal
Journal:  Clin Pharmacokinet       Date:  1979 May-Jun       Impact factor: 6.447

Review 2.  The pharmacological role of the kidney.

Authors:  D C Brater
Journal:  Drugs       Date:  1980-01       Impact factor: 9.546

Review 3.  Tobramycin: a review of its antibacterial and pharmacokinetic properties and therapeutic use.

Authors:  R N Brogden; R M Pinder; P R Sawyer; T M Speight; G S Avery
Journal:  Drugs       Date:  1976       Impact factor: 9.546

4.  Isepamicin disposition in subjects with various degrees of renal function.

Authors:  C E Halstenson; J S Kelloway; M B Affrime; C C Lin; M A Teal; B E Shapiro; W M Awni
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

5.  Accumulation pharmacokinetics of tobramycin.

Authors:  J J Schentag; G Lasezkay; T J Cumbo; M E Plaut; W J Jusko
Journal:  Antimicrob Agents Chemother       Date:  1978-04       Impact factor: 5.191

6.  Antibiotic blood concentrations in patients successfully treated with tobramycin.

Authors:  M Fiala; S N Chatterjee
Journal:  Postgrad Med J       Date:  1981-09       Impact factor: 2.401

7.  Pharmacokinetics of netilmicin in patients with renal impairment and in patients on dialysis.

Authors:  F C Luft; D R Brannon; L L Stropes; R J Costello; R S Sloan; D R Maxwell
Journal:  Antimicrob Agents Chemother       Date:  1978-09       Impact factor: 5.191

8.  Differences in kinetic properties of drugs: implications as to the selection of a particular drug for use in patients with renal failure with special emphasis on antibiotics and beta-adrenoceptor blocking agents.

Authors:  J Fabre; H M Fox; P Dayer; L Balant
Journal:  Clin Pharmacokinet       Date:  1980 Sep-Oct       Impact factor: 6.447

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.